The ENERGIZE study compared the efficacy and safety of mitapivat, an pyruvate kinase activator, with placebo in adults with TD alpha- or beta-thalassemia.
The Galien Foundation's Prix Galien UK Forum Returns to London in May 2024 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Insider Selling: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Insider Sells 642 Shares of Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Insider Sarah Gheuens Sells 642 Shares dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Agios Pharma (AGIO) Reports Phase 3 ENERGIZE Study of Mitapivat Met Primary Endpoint and Both Key Secondary Endpoints streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.